BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19608273)

  • 1. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA
    Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
    McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
    Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Abnormal expression of transcription factors LYL1 and LMO2 and interaction between them in myeloid leukemia].
    Meng YS; Wei R; Ai GW; Meng XQ; Zhang YX
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):890-3. PubMed ID: 19671288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyl1 interacts with CREB1 and alters expression of CREB1 target genes.
    San-Marina S; Han Y; Suarez Saiz F; Trus MR; Minden MD
    Biochim Biophys Acta; 2008 Mar; 1783(3):503-17. PubMed ID: 18160048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of transcription factor LYL1 in leukemia and its possible role in leukemogenesis].
    Meng YS; Zhang YX; Ai GW; Meng XQ; Liu W; Wei R; Jiang W
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):749-52. PubMed ID: 19176012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements.
    Homminga I; Vuerhard MJ; Langerak AW; Buijs-Gladdines J; Pieters R; Meijerink JP
    Haematologica; 2012 Feb; 97(2):258-61. PubMed ID: 22058201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
    Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
    PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression.
    San-Marina S; Han Y; Liu J; Minden MD
    Biochim Biophys Acta; 2012; 1819(11-12):1164-72. PubMed ID: 23000483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
    Meng YS; Khoury H; Dick JE; Minden MD
    Leukemia; 2005 Nov; 19(11):1941-7. PubMed ID: 16094422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
    Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise review: Blood relatives: formation and regulation of hematopoietic stem cells by the basic helix-loop-helix transcription factors stem cell leukemia and lymphoblastic leukemia-derived sequence 1.
    Curtis DJ; Salmon JM; Pimanda JE
    Stem Cells; 2012 Jun; 30(6):1053-8. PubMed ID: 22593015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
    Xia Y; Hwang LY; Cobb MH; Baer R
    Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia.
    Tan SH; Yam AW; Lawton LN; Wong RW; Young RA; Look AT; Sanda T
    Leukemia; 2016 Apr; 30(4):959-62. PubMed ID: 26202930
    [No Abstract]   [Full Text] [Related]  

  • 16. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
    Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
    Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
    Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
    Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
    Hofmann TJ; Cole MD
    Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Demonstration of leukemic stem cells in the human T-ALLs and study of the involvement of the NOTCH, TAL1 and ERK/MAPK pathways in human T-leukemogenesis].
    Gerby B; Armstrong F; Brunet de la Grange P; Calvo J; Ballerini P; Pflumio F
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S28-9. PubMed ID: 18984291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.